CA2406195A1 - Lipid binding protein 4 - Google Patents

Lipid binding protein 4 Download PDF

Info

Publication number
CA2406195A1
CA2406195A1 CA002406195A CA2406195A CA2406195A1 CA 2406195 A1 CA2406195 A1 CA 2406195A1 CA 002406195 A CA002406195 A CA 002406195A CA 2406195 A CA2406195 A CA 2406195A CA 2406195 A1 CA2406195 A1 CA 2406195A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
leu
polynucleotide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002406195A
Other languages
English (en)
French (fr)
Inventor
Matthias Grell
Klaus Ducker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2406195A1 publication Critical patent/CA2406195A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002406195A 2000-04-18 2001-04-11 Lipid binding protein 4 Abandoned CA2406195A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00107995.3 2000-04-18
EP00107995 2000-04-18
PCT/EP2001/004170 WO2001079269A2 (en) 2000-04-18 2001-04-11 Lipid binding protein 4

Publications (1)

Publication Number Publication Date
CA2406195A1 true CA2406195A1 (en) 2001-10-25

Family

ID=8168455

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002406195A Abandoned CA2406195A1 (en) 2000-04-18 2001-04-11 Lipid binding protein 4

Country Status (5)

Country Link
US (1) US6924357B2 (enExample)
EP (1) EP1274842A2 (enExample)
JP (1) JP2004500829A (enExample)
CA (1) CA2406195A1 (enExample)
WO (1) WO2001079269A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139573A1 (en) * 2000-04-18 2003-07-24 Matthias Grell Lipid binding protein 3
EP2749569A1 (en) * 2012-12-28 2014-07-02 Annibale Alessandro Puca Variant of BPIFB4 protein
ES2970198T3 (es) 2017-08-16 2024-05-27 Lgv1 S R L Isoforma VTFT de una proteína BPIFB4 para uso en enfermedades y lesiones neuronales

Also Published As

Publication number Publication date
WO2001079269A2 (en) 2001-10-25
US20030124582A1 (en) 2003-07-03
JP2004500829A (ja) 2004-01-15
US6924357B2 (en) 2005-08-02
WO2001079269A3 (en) 2002-03-07
EP1274842A2 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
US6924357B2 (en) Lipid binding protein 4
CA2407893A1 (en) New gtpase-activating protein 1
CA2408828A1 (en) Novel serine-threonine kinase-4
US20030139573A1 (en) Lipid binding protein 3
CA2400606A1 (en) New phosphodiesterase type 7b
US20060216750A1 (en) New lipid binding protein 1
US20060036074A1 (en) Bromodomain protein
CA2408468A1 (en) Serine-threonine kinase-3
US20040143102A1 (en) Histidine phosphatase interacting protein with 240kd
CA2406087A1 (en) New lipid binding protein 2
CA2417271A1 (en) Novel protein inhibitor of apoptosis proteins
EP1290175A1 (en) Scramblase 2
CA2400794A1 (en) New transcription factor carp-2
CA2418198A1 (en) Novel protein containing ring finger domaine r1p4
CA2406448A1 (en) Identification of a human gaba transporter
US20030143654A1 (en) F-box containing protein
US20040054136A1 (en) New human tap- like protein
CA2417278A1 (en) Identification of a novel glutamine transporter
CA2419872A1 (en) Identification of a human n-terminal acetyltransferase gene
AU2002228077A1 (en) Histidine phosphatase interacting protein with 240KD
CA2405181A1 (en) Human pyruvate dehydrogenese phosphatase
CA2438371A1 (en) Histidine phosphatase interacting protein of 120 kd
AU2002252983A1 (en) Histidine phosphatase interacting protein of 120KD

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead